Kidswell Bio Corporation (TYO:4584)
Japan flag Japan · Delayed Price · Currency is JPY
177.00
-3.00 (-1.67%)
Aug 27, 2026, 1:19 PM JST

Kidswell Bio Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2022FY 2021FY 2020
Period EndingJun '26 Mar '26 Mar '25 Mar '22 Mar '21 Mar '20
Revenue
6,1376,5895,0821,5699961,077
Revenue Growth
-2.89%29.65%223.90%57.53%-7.52%5.41%
Gross Profit
1,3561,5231,4331,018876423
Operating Income
-107.65-13928-919-970-1,162
Net Income
-373.13-413-21-535-1,001-7,316
Earnings Per Share
-7.56-8.46-0.52-17.34-34.77-264.64
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2022FY 2021FY 2020
Period EndingJun '26 Mar '26 Mar '25 Mar '22 Mar '21 Mar '20
Cash & Investments
3,2333,2942,9951,1871,4612,032
Total Debt
2,4752,5491,8377001,1001,225
Net Cash (Debt)
7587451,158487361807
Net Cash Growth
-41.30%-35.66%137.78%34.90%-55.27%-59.84%
Net Cash Per Share
15.3615.2728.5915.7912.5429.19

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2022FY 2021FY 2020
Period EndingJun '26 Mar '26 Mar '25 Mar '22 Mar '21 Mar '20
Operating Cash Flow
--1,096936-1,169-1,267-1,325
Capital Expenditures
--17-6---1
Free Cash Flow
--1,113930-1,169-1,267-1,326
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2022FY 2021FY 2020
Period EndingJun '26 Mar '26 Mar '25 Mar '22 Mar '21 Mar '20
Gross Margin
22.09%23.11%28.20%64.88%87.95%39.28%
Operating Margin
-1.75%-2.11%0.55%-58.57%-97.39%-107.89%
Pretax Margin
-5.57%-6.10%1.44%-34.03%-100.40%-679.11%
Profit Margin
-6.08%-6.27%-0.41%-34.10%-100.50%-679.29%
FCF Margin
--16.89%18.30%-74.51%-127.21%-123.12%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2022FY 2021FY 2020
Period EndingAug '26 Mar '26 Mar '25 Mar '22 Mar '21 Mar '20
Forward PE
8.2314.2515.50---
P/FCF Ratio
--5.18---
PS Ratio
1.481.830.959.2214.9913.45